Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.00
-0.53 (-1.25%)
At close: Mar 5, 2026, 4:00 PM EST
41.19
-0.81 (-1.93%)
After-hours: Mar 5, 2026, 5:37 PM EST

Terns Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
----1-
Gross Profit
----1-
Selling, General & Admin
31.4831.7639.0622.4119.559
Research & Development
76.9970.1163.539.6231.3128.03
Total Operating Expenses
108.48101.87102.5662.0350.8637.03
Operating Income
-108.48-101.87-102.56-62.03-49.86-37.03
Interest Income
14.2813.2912.92.110.170.06
Other Non-Operating Income (Expense)
0-0.01-0.31-0.070.04-2.79
Total Non-Operating Income (Expense)
14.2813.2812.592.040.21-2.73
Pretax Income
-94.2-88.59-89.97-59.99-49.65-39.76
Provision for Income Taxes
0.240.260.240.360.510.81
Net Income
-94.44-88.85-90.21-60.35-50.16-29.35
Minority Interest in Earnings
------0.52
Net Income Attributable to Preferred Dividends
------10.7
Net Income to Common
-94.44-88.85-90.21-60.35-50.16-29.35
Shares Outstanding (Basic)
91807136230
Shares Outstanding (Diluted)
91807136230
Shares Change (YoY)
22.40%11.58%97.76%58.69%7862.47%55.60%
EPS (Basic)
-1.03-1.12-1.27-1.67-2.21-102.93
EPS (Diluted)
-1.03-1.12-1.27-1.67-2.21-102.93
Free Cash Flow
-77.68-70.06-67.44-49.38-42.17-30.39
Free Cash Flow Per Share
-0.85-0.88-0.95-1.37-1.86-106.58
Gross Margin
----100.00%-
Operating Margin
-----4986.00%-
Profit Margin
-----5015.80%-
FCF Margin
-----4216.70%-
EBITDA
-107.87-100.98-101.68-61-49.35-36.63
EBITDA Margin
-----4934.80%-
EBIT
-108.48-101.87-102.56-62.03-49.86-37.03
EBIT Margin
-----4986.00%-
Effective Tax Rate
-0.25%-0.29%-0.27%-0.60%-1.02%-2.04%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q